Insmed Incorporated
INSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,326 | $4,352 | $2,458 | $3,054 |
| - Cash | $555 | $482 | $1,074 | $717 |
| + Debt | $1,310 | $1,204 | $1,178 | $612 |
| Enterprise Value | $12,080 | $5,074 | $2,562 | $2,949 |
| Revenue | $364 | $305 | $245 | $188 |
| % Growth | 19.2% | 24.4% | 30.2% | – |
| Gross Profit | $278 | $240 | $190 | $144 |
| % Margin | 76.4% | 78.5% | 77.5% | 76.6% |
| EBITDA | -$819 | -$660 | -$447 | -$384 |
| % Margin | -225.1% | -216.3% | -182.3% | -203.6% |
| Net Income | -$914 | -$750 | -$482 | -$435 |
| % Margin | -251.2% | -245.6% | -196.3% | -230.6% |
| EPS Diluted | -5.57 | -5.34 | -3.91 | -3.88 |
| % Growth | -4.3% | -36.6% | -0.8% | – |
| Operating Cash Flow | -$684 | -$536 | -$400 | -$363 |
| Capital Expenditures | -$22 | -$13 | -$10 | -$7 |
| Free Cash Flow | -$706 | -$550 | -$410 | -$371 |